Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients

Hantke B, Harbeck N, Schmalfeldt B, Claes I, Hiller O, Luther MO, Welk A, Kuhn W, Schmitt M, Tschesche H, Muehlenweg B (2003)
BIOLOGICAL CHEMISTRY 384(8): 1247-1251.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ;
Abstract / Bemerkung
Matrix metalloproteinases (MMPs) are involved in many physiological and pathophysiological processes, including tumor cell invasion and metastasis. For one member of this family, MMP-13 (collagenase-3), a new, highly specific ELISA with a sensitivity of 0.5 ng MMP-13/ml was established. The protein levels of MMP-13 in ascitic fluids of 30 patients with advanced ovarian cancer FIGO stage III (n=19) and IV (n=11) were measured with this ELISA. Using a cutoff value of 0.5 ng MMP-13/mg total protein, two patient subpopulations with short (median 16 months) and long (median 36 months) overall survival were identified. Together with other prognostic markers, determination of MMP-13 in ascitic fluid may help to identify patients at risk for early death and help to individualize adjuvant therapy.
Erscheinungsjahr
Zeitschriftentitel
BIOLOGICAL CHEMISTRY
Band
384
Zeitschriftennummer
8
Seite
1247-1251
ISSN
PUB-ID

Zitieren

Hantke B, Harbeck N, Schmalfeldt B, et al. Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients. BIOLOGICAL CHEMISTRY. 2003;384(8):1247-1251.
Hantke, B., Harbeck, N., Schmalfeldt, B., Claes, I., Hiller, O., Luther, M. O., Welk, A., et al. (2003). Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients. BIOLOGICAL CHEMISTRY, 384(8), 1247-1251. doi:10.1515/BC.2003.137
Hantke, B., Harbeck, N., Schmalfeldt, B., Claes, I., Hiller, O., Luther, M. O., Welk, A., Kuhn, W., Schmitt, M., Tschesche, H., et al. (2003). Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients. BIOLOGICAL CHEMISTRY 384, 1247-1251.
Hantke, B., et al., 2003. Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients. BIOLOGICAL CHEMISTRY, 384(8), p 1247-1251.
B. Hantke, et al., “Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients”, BIOLOGICAL CHEMISTRY, vol. 384, 2003, pp. 1247-1251.
Hantke, B., Harbeck, N., Schmalfeldt, B., Claes, I., Hiller, O., Luther, M.O., Welk, A., Kuhn, W., Schmitt, M., Tschesche, H., Muehlenweg, B.: Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients. BIOLOGICAL CHEMISTRY. 384, 1247-1251 (2003).
Hantke, B, Harbeck, N, Schmalfeldt, B, Claes, I, Hiller, O, Luther, MO, Welk, A, Kuhn, W, Schmitt, M, Tschesche, Harald, and Muehlenweg, B. “Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients”. BIOLOGICAL CHEMISTRY 384.8 (2003): 1247-1251.

4 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

The Long Noncoding RNA MALAT-1 Is Highly Expressed in Ovarian Cancer and Induces Cell Growth and Migration.
Zhou Y, Xu X, Lv H, Wen Q, Li J, Tan L, Li J, Sheng X., PLoS One 11(5), 2016
PMID: 27227769
Ovarian cancer: involvement of the matrix metalloproteinases.
Al-Alem L, Curry TE., Reproduction 150(2), 2015
PMID: 25918438
Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells.
Wang ZQ, Keita M, Bachvarova M, Gobeil S, Morin C, Plante M, Gregoire J, Renaud MC, Sebastianelli A, Trinh XB, Bachvarov D., PLoS One 8(10), 2013
PMID: 24124450
CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
Johnson EL, Singh R, Singh S, Johnson-Holiday CM, Grizzle WE, Partridge EE, Lillard JW., World J Surg Oncol 8(), 2010
PMID: 20649989

28 References

Daten bereitgestellt von Europe PubMed Central.


Tamei, Connective Tissue 30(), 1998

Tschesche, J. Prot. Chem. 17(), 1998
Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis.
Wernicke D, Seyfert C, Hinzmann B, Gromnica-Ihle E., J. Rheumatol. 23(4), 1996
PMID: 8730110

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 12974393
PubMed | Europe PMC

Suchen in

Google Scholar